Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Infectious Diseases Drugs 243
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 174
Immune Disorders Drugs 153
Animal Pharmaceuticals 133
Women's Health 133
Central Nervous System Drugs 132
Cardiovascular Drugs 124
Pharmaceuticals 113
Musculoskeletal Disorders Drugs 102
Drug Discovery 97
Biopharmaceuticals 92
Respiratory Drugs 81
Oncology 74
Clinical Trials 72
Allergy and Immunology 71
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 61
Biotechnology 60
Gastrointestinal Drugs 60
Drug Delivery 59
Enzymes 57
Genomics 49
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 37
Diagnostics 36
Pulmonary Medicine 35
Lymphoma Drugs 35
Cancer Vaccines 33
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Pharmaceutical Intermediates 31
Lung Cancer Drugs 29
Urological Disorders Drugs 29
Optical 28
Pharmaceutical Manufacturing 28
HIV/AIDS Drugs 27
Liver Cancer Drugs 26
Over the Counter (OTC) Drugs 25
Healthcare Services 24
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Cardiology 21
Leukemia Drugs 20
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
Vitamins and Dietary Supplements 16
Bladder Cancer Drugs 15
Biomarkers 15
E-Healthcare 14
Medical Devices 14
Hematology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Gastroenterology 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Transdermal and Transmucosal Drug Delivery 10
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Bronchitis Drugs 7
Healthcare 6
Needles and Syringes 6
Uterine Cancer Drugs 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Proteomics 5
Hepatology 4
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

3,356 Results (Page 43 of 168)
- Relevance
  Sort by

Oropharyngeal Candidiasis Market - Global Strategic Business Report

 Report
May 2026
462 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Pseudomonas Aeruginosa Infection Treatment Market - Global Strategic Business Report

 Report
May 2026
273 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Encephalitis Treatment - Global Strategic Business Report

 Report
May 2026
478 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
May 2026
294 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Cryptococcosis Therapeutics - Global Strategic Business Report

 Report
May 2026
473 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Oral Antivirals Market - Global Strategic Business Report

 Report
May 2026
380 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Antifungal Drugs - Global Strategic Business Report

 Report
May 2026
179 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Rabies Treatment - Global Strategic Business Report

 Report
May 2026
179 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Hospital Acquired Infection Treatment - Global Strategic Business Report

 Report
May 2026
291 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Aspergillosis Drugs - Global Strategic Business Report

 Report
May 2026
373 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
May 2026
384 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Caspofungin - Global Strategic Business Report

 Report
May 2026
279 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Infectious Disease Therapeutics - Global Strategic Business Report

 Report
May 2026
385 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Clostridium Difficile Treatment - Global Strategic Business Report

 Report
May 2026
374 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

MRSA Drugs - Global Strategic Business Report

 Report
May 2026
221 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Bird Flu Treatment Market - Global Strategic Business Report

 Report
May 2026
285 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Candidiasis Therapeutics Market - Global Strategic Business Report

 Report
May 2026
474 Pages
Global

From

€5210EUR$5,850USD£4,543GBP

Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
168 Pages
Global

€4448EUR$4,995USD£3,879GBP

Contraceptive Pills Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4407EUR$4,949USD£3,843GBP

Contraceptive Drugs Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4407EUR$4,949USD£3,843GBP

3,356 Results (Page 43 of 168)
- 1
- 41
- 42
- 43
- 44
- 45

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.